Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Adebrelimab Plus Chemotherapy in Resectable NSCLC
NCT07895238Phase 3Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2026
- Primary completion
- Dec 2032
01
Overview
A Phase 3 trial of adebrelimab in non-small cell lung cancer (NSCLC), sponsored by West China Hospital of Sichuan University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
adebrelimab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07895238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07895238.